This report was published in 2006. For more recent information, please see page 4 of the Pharmacovigilance Working Party’s monthly report from July 2012
01 November 2006
Dopamine agonists are used to treat Parkinson's disease and restless legs syndrome.
A European review has concluded that side effects such as pathological gambling and increased libido (increased sex drive) may occur with the use of any dopamine agonist.
This safety concern was also highlighted in an issue of our publication August 2007 edition of Drug Safety Update (page 6) (124Kb).
This report presents the evidence that was available when the regulatory decision was made, showing a ‘snapshot’ of the clinical landscape at the time. However, any advice in this report remains current unless it is superseded by a more recent report (where relevant, this is indicated).